|
J1956 |
Injection, levofloxacin, 250 mg |
3 |
11/14/2008 |
|
|
J1980
|
Injection, hyoscyamine sulfate, up to 0.25 mg |
6 |
12/16/2008 |
|
|
J2001 |
Injection, lidocaine HCl for intravenous infusion, 10 mg
|
210 |
12/16/2008 |
|
|
J2010
|
Injection, lincomycin HCl, up to 300 mg |
7 |
12/3/2008 |
|
| J2020 | Injection, linezolid, 200
mg | 3 | 7/17/2009 | |
|
J2060 |
Injection, lorazepam, 2 mg
|
4 |
12/16/2008 |
|
|
J2150
|
Injection, mannitol, 25% in 50 ml |
8 |
12/16/2008 |
7/1/2010 |
|
J2175 |
Injection, meperidine HCl, per 100 mg |
3 |
12/3/2008 |
|
4 |
J2180
|
Injection, meperidine and promethazine HCl, up to 50
mg |
0 |
11/21/2008 |
|
|
J2185 |
Injection, meropenem, 100 mg |
88 |
12/16/2008 |
|
|
J2210
|
Injection, methylergonovine maleate, up to 0.2 mg |
3 |
12/16/2008 |
7/1/2010 |
|
J2250 |
Injection, midazolam hydrochloride, per 1 mg |
22 |
12/16/2008 |
|
|
J2270
|
Injection, morphine sulfate, up to 10 mg |
3 |
11/14/2008 |
7/1/2010 |
|
J2271 |
Injection, morphine sulfate, 100 mg |
1 |
11/14/2008 |
|
5 |
J2275
|
Injection, morphine sulfate (preservative-free sterile
solution), per 10 mg |
15 |
12/3/2008 |
|
| J2280 | Injection, moxifloxacin, 100
mg | 4 | 7/17/2009 | |
|
J2300 |
Injection, nalbuphine HCl, per 10 mg
|
16 |
11/14/2008 |
|
|
J2310
|
Injection, naloxone hydrochloride, per 1 mg |
10 |
12/16/2008 |
|
|
J2320 |
Injection, nandrolone deconoate, up to 50 mg |
4 |
12/16/2008 |
|
| J2321 | Injection, nandrolone deconoate, up
to 100 mg | 2 | 7/17/2009 | |
| J2322 | Injection, nandrolone decanoate, up
to 200 mg | 1 | 4/1/2010 | |
|
J2323 |
Injection, natalizumab, 1 mg |
300
|
11/14/2008 |
|
|
J2353 |
Injection, octreotide, depot form for intramuscular injection,
1 mg |
30 |
12/16/2008
|
Denied |
3
|
J2354 |
Injection, octreotide, non-depot form for subcutaneous or
intravenous injection, 25 mcg |
0 |
12/16/2008 |
|
|
J2355 |
Injection, oprelvekin, 5 mg |
1 |
11/14/2008
|
|
5
|
J2357 |
Injection, omalizumab, 5 mg |
75 |
12/16/2008 |
|
|
J2360 |
Injection, orphenadrine citrate, up to 60 mg |
1 |
12/3/2008
|
|
|
J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
50
|
12/16/2008 |
|
|
J2410 |
Injection, oxymorphone HCl, up to 1 mg |
5 |
12/16/2008
|
|
|
J2430 |
Injection, pamidronate disodium, per 30 mg |
3
|
11/14/2008 |
|
|
J2440 |
Injection, papaverine HCl, up to 60 mg |
2 |
11/14/2008
|
|
| J2460 | Injection, oxytetracycline HCl, up
to 50 mg | 5 | 7/17/2009 | |
|
J2469 |
Injection, palonosetron HCl, 25 mcg |
10 |
11/14/2008 |
|
|
J2503
|
Injection, pegaptanib sodium, 0.3 mg |
2 |
11/14/2008 |
|
|
J2505 |
Injection, pegfilgrastim, 6 mg |
1 |
11/7/2008 |
|
|
J2510
|
Injection, penicillin G procaine, aqueous, up to 600,000
units |
4 |
11/14/2008 |
7/1/2010 |
|
J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125
grams (1.125 grams) |
12 |
12/16/2008 |
6/1/2010
|
|
J2550
|
Injection, promethazine HCl, up to 50 mg |
3 |
12/3/2008 |
|
| J2562 | Injection, plerixafor, 1
mg | 40 | 1/1/2010 | |
|
J2597 |
Injection, desmopressin acetate, per 1 mcg
|
32 |
12/16/2008 |
|
4 |
J2650 |
Injection, prednisolone acetate, up to 1 ml |
0
|
11/21/2008 |
|
3 |
J2675 |
Injection, progesterone, per 50 mg |
0 |
11/21/2008
|
|
|
J2680 |
Injection, fluphenazine decanoate, up to 25 mg |
4
|
11/14/2008 |
|
|
J2690 |
Injection, procainamide HCl, up to 1 gram |
1 |
11/14/2008
|
|
|
J2720 |
Injection, protamine sulfate, per 10 mg |
5
|
11/14/2008 |
|
|
J2760 |
Injection, phentolamine mesylate, up to 5 mg |
1 |
11/14/2008
|
|
|
J2765 |
Injection, metoclopramide HCl, up to 10 mg |
132
|
12/16/2008 |
|
|
J2778 |
Injection, ranibizumab, 0.1 mg |
10 |
12/16/2008
|
|
|
J2780 |
Injection, ranitidine hydrochloride, 25 mg |
4
|
12/16/2008 |
|
8 |
J2785 |
Injection, regadenoson, 0.1 mg |
4 |
12/16/2008
|
|
| J2788 |
Injection, RHo D immune globulin,
human, minidose, 50 micrograms | 1 | 7/1/2010 | |
|
J2790 |
Injection, RHo D immune globulin, human, full dose, 300
micrograms (1500 IU) |
1 |
11/14/2008
|
|
| J2791 |
Injection, RHo D immune globulin, human, IM or IV, 100
IU | 275 | 7/1/2010 | |
|
J2792 |
Injection, RHo D immune globulin, intravenous, human, solvent
detergent, 100 IU |
300 |
11/14/2008
|
7/1/2010 |
5 | J2793 | Injection, rilonacept, 1
mg | 440 | 1/1/2010 | |
|
J2794 |
Injection, risperidone, long acting, 0.5 mg |
100 |
11/14/2008 |
|
5 |
J2795
|
Injection, ropivacaine hydrochloride, 1 mg |
300 |
12/16/2008 |
|
5 | J2796 | Injection, romiplostim, 10
micrograms | 150 | 1/1/2010 | |
|
J2800 |
Injection, methocarbamol, up to 10 ml
|
2 |
12/3/2008 |
|
|
J2805
|
Injection, sincalide, 5 micrograms |
1 |
11/14/2008 |
|
5 |
J2820 |
Injection, sargramostim (GM-CSF), 50 mcg
|
15 |
11/14/2008 |
2/17/2009 |
|
J2910 |
Injection, aurothioglucose, up to 50 mg |
1
|
11/14/2008 |
|
4 |
J2912 |
Injection, sodium chloride, 0.9%, per 2 ml |
0 |
11/14/2008
|
|
|
J2916 |
Injection, sodium ferric gluconate complex in sucrose
injection, 12.5 mg |
10
|
12/16/2008 |
|
|
J2920 |
Injection, methylprednisolone sodium succinate, up to 40
mg |
83 |
12/16/2008
|
|
|
J2930 |
Injection, methylprednisolone sodium succinate, up to 125
mg |
27
|
12/16/2008 |
|
3 |
J2941 |
Injection, somatropin, 1 mg |
0 |
11/21/2008
|
|
|
J2950 |
Injection, promazine HCl, up to 25 mg |
8
|
12/16/2008 |
|
|
J2997 |
Injection, alteplase recombinant, 1 mg |
100 |
12/16/2008
|
|
|
J3000 |
Injection, streptomycin, up to 1 gram |
2
|
12/3/2008 |
|
5 |
J3010 |
Injection, fentanyl citrate, 0.1 mg |
3 |
12/3/2008
|
|
3
|
J3030 |
Injection, sumatriptan succinate, 6 mg (only for direct
physician supervision administration) |
0 |
11/21/2008 |
|
|
J3070 |
Injection, pentazocine, 30 mg |
4 |
12/16/2008
|
|
1 | J3100 | Injection, tenecteplase, 50
mg | 1 | 7/17/2009 | |
8 |
J3101 |
Injection, tenecteplase, 1 mg
|
50 |
12/16/2008 |
|
|
J3105
|
Injection, terbutaline sulfate, up to 1 mg |
1 |
11/14/2008 |
|
|
J3120 |
Injection, testosterone enanthate, up to 100 mg |
4 |
12/3/2008 |
|
|
J3130
|
Injection, testosterone enanthate, up to 200 mg |
2 |
11/14/2008 |
|
4 |
J3140 |
Injection, testosterone suspension, up to 50 mg
|
0 |
11/21/2008 |
|
4 |
J3150 |
Injection, testosterone propionate, up to 100 mg |
0
|
11/21/2008 |
|
|
J3230 |
Injection, chlorpromazine HCl, up to 50 mg |
4 |
12/16/2008
|
|
|
J3240 |
Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg
vial |
1
|
11/14/2008 |
|
|
J3243 |
Injection, tigecycline, 1 mg |
100 |
11/14/2008
|
|
|
J3250 |
Injection, trimethobenzamide HCl, up to 200 mg |
2
|
11/14/2008 |
|
|
J3260 |
Injection, tobramycin sulfate, up to 80 mg |
5 |
12/16/2008
|
|
|
J3265 |
Injection, torsemide, 10 mg/ml |
2
|
11/14/2008 |
|
8 |
J3300 |
Injection, triamcinolone acetonide, preservative free, 1
mg |
40 |
12/16/2008
|
|
|
J3301 |
Injection, triamcinolone acetonide, not otherwise specified,
per 10 mg |
16
|
12/16/2008 |
|
4 |
J3302 |
Injection, triamcinolone diacetate, per 5 mg |
0 |
11/21/2008
|
|
|
J3303 |
Injection, triamcinolone hexacetonide, per 5 mg |
12
|
12/16/2008 |
4/10/2009 |
|
J3315 |
Injection, triptorelin pamoate, 3.75 mg |
6 |
11/14/2008
|
7/1/2010 |
|
J3360 |
Injection, diazepam, up to 5 mg |
6 |
12/16/2008 |
|
|
J3370 |
Injection, vancomycin HCl, 500 mg |
8 |
12/16/2008
|
9/18/2009 |
|
J3396 |
Injection, verteporfin, 0.1 mg |
150 |
12/16/2008 |
|
|
J3410 |
Injection, hydroxyzine HCl, up to 25 mg |
12 |
12/16/2008
|
|
|
J3411 |
Injection, thiamine HCl, 100 mg |
1
|
11/21/2008 |
|
|
J3420 |
Injection, vitamin B-12 cyanocobalamin, up to 1000
mcg |
1 |
11/21/2008
|
|
|
J3430 |
Injection, phytonadione (vitamin K), per 1 mg |
100
|
12/16/2008 |
|
|
J3470 |
Injection, hyaluronidase, up to 150 units |
2 |
11/21/2008
|
|
|
J3471 |
Injection hyaluronidase, ovine, preservative free, per 1 usp
unit (up to 999 USP units) |
400
|
12/16/2008 |
|
| J3473 | Injection, hyaluronidase,
recombinant, 1 USP unit | 300 | 7/17/2009 | |
|
J3475
|
Injection, magnesium sulfate, per 500 mg |
48 |
12/16/2008 |
|
|
J3480 |
Injection, potassium chloride, per 2 mEq |
60 |
12/16/2008 |
|
|
J3486
|
Injection, ziprasidone mesylate, 10 mg |
4 |
11/21/2008 |
|
|
J3487 |
Injection, zoledronic acid, 1 mg |
4 |
12/3/2008 |
|
|
J3488
|
Injection, zoledronic acid, 1 mg |
5 |
11/21/2008 |
|
2 |
J3520 |
Edetate disodium, per 150 mg
|
0 |
11/21/2008 |
|
2 |
J3535 |
Drug administered through a metered dose inhaler |
0
|
11/21/2008 |
|
|
J7030 |
Infusion, normal saline solution, 1000 cc |
2 |
12/16/2008
|
|
|
J7040 |
Infusion, normal saline solution, sterile (500 ml = 1
unit) |
4
|
12/3/2008 |
|
|
J7042 |
5% dextrose/normal saline solution (500 ml = 1
unit) |
4 |
12/3/2008
|
|
|
J7050 |
Infusion, normal saline solution , 250 cc |
8
|
12/16/2008 |
|
|
J7060 |
5% dextrose/water (500 ml = 1 unit) |
4 |
12/3/2008
|
|
|
J7070 |
Infusion, D5W, 1000 cc |
2
|
11/21/2008 |
|
| J7100 | Infusion, dextran 40, 500
ml | 2 | 7/1/2010 | |
| J7110 | Infusion, dextran 75, 500
ml | 2 | 7/1/2010 | |
|
J7120
|
Ringers lactate infusion, up to 1000 cc |
4 |
12/3/2008 |
7/1/2010 |
2 |
J7130 |
Hypertonic saline solution, 50 or 100 mEq, 20 cc
vial
|
0 |
11/21/2008 |
|
5 | J7185 | Injection, factor VII
(antihemophilic factor, recombinant) (Xyntha), per I.U. | 5500 | 1/1/2010 | |
8
|
J7186 |
Injection, antihemophilic factor VIII/Von Willebrand factor
complex (human), per factor VIII IU |
5500 |
12/16/2008 |
|
5 |
J7192 |
Factor VIII (antihemophilic factor, recombinant) per
IU |
5500 |
12/16/2008
|
|
2
|
J7300 |
Intrauterine copper contraceptive |
0 |
11/21/2008 |
|
2 |
J7302 |
Levonorgestrel-releasing intrauterine contraceptive system, 52
mg |
0 |
11/21/2008
|
|
|
J7308 |
Aminolevulinic acid HCl for topical administration, 20%,
single unit dosage form |
2
|
11/21/2008 |
|
|
J7311 |
Fluocinolone acetonide, intravitreal implant
(Retisert) |
1 |
11/21/2008
|
4/1/2010 |
2
|
J7317 |
Sodium hyaluronate, per 20 to 25 mg dose for intra-articular
injection |
0 |
11/21/2008 |
|
|
J7321 |
Hyaluronan or derivative, Hyalgan or Supartz, for
intra-articular injection, per dose |
2 |
11/21/2008
|
|
9
|
J7322 |
Hyaluronan or derivative, Synvisc, for intra-articular
injection, per dose |
2 |
11/21/2008 | |
|
J7323 |
Hyaluronan or derivative, Euflexxa, for intra-articular
injection, per dose
|
2 |
11/21/2008 |
|
|
J7324
|
Hyaluronan or derivative, Orthovisc, for intra-articular
injection, per dose |
2 |
11/21/2008 |
|
| J7325 |
Hyaluronan or derivative, Synvisc or Synvisc-One, for
intra-articular injection, 1 mg | 96 | 1/1/2010 | |
2 |
J7502 |
Cyclosporine, oral 100 mg |
0 |
12/16/2008
|
|
2
|
J7506 |
Prednisone, oral, per 5 mg |
0 |
12/16/2008 |
|
2 |
J7510 |
Prednisolone, oral, per 5 mg |
0 |
12/16/2008
|
|
|
J7513 |
Daclizumab, parenteral, 25 mg |
5
|
11/21/2008 |
|
2 |
J7515 |
Cyclosporine, oral, 25 mg |
0 |
12/16/2008
|
|
7
|
J7602 |
Albuterol, all formulations including separated isomers,
inhalation, solution, FDA-approved final product, non-compounded, administered through DME,
concentrated form, per 1 mg (albuterol) or per 0.5 mg (levalbuterol) |
3 |
12/16/2008 |
|
7 |
J7603 |
Albuterol, all formulations including separated isomers,
inhalation solution, FDA-approved final product, non-compounded, administered through DME,
unit dose, per 1 mg (albuterol) or per 0.5 mg (levalbuterol) |
3 |
12/16/2008
|
|
8
|
J7606 |
Formoterol fumarate, inhalation solution, FDA-approved final
product, non-compounded, administered through DME, unit dose form, 20 micrograms |
1 |
12/16/2008 |
|
|
J7607
|
Levalbuterol, inhalation solution, compounded product,
administered through DME, concentrated form, 0.5 mg |
3 |
12/16/2008 |
|
|
J7615 |
Levalbuterol inhalation solution, compounded product,
administered through DME, unit dose, 0.5 mg |
3 |
12/16/2008 |
|
|
J7620
|
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg,
FDA-approved final product, non-compounded, administered through DME |
1 |
12/16/2008 |
|
|
J7626 |
Budesonide, inhalation solution, FDA-approved final product,
non-compounded, administered trough DME, unit dose form, up to 0.5 mg |
2 |
12/16/2008 |
|
4 |
J7628
|
Bitolterol mesylate, inhalation solution, compounded product,
administered through DME, concentrated form, per mg |
0 |
11/21/2008 |
|
4 |
J7636 |
Atropine, inhalation solution, compounded product,
administered through DME, unit dose form, per mg
|
0 |
11/21/2008 |
|
|
J7638
|
Dexamethasone, inhalation solution, compounded product,
administered through DME, unit dose form, per mg |
10 |
12/16/2008 |
|
3 |
J7639 |
Dornase alpha, inhalation solution, FDA-approved final
product, non-compounded, administered through DME, unit dose form, per mg
|
0 |
12/16/2008 |
|
3 |
J7641 |
Flunisolide, inhalation solution, compounded product,
administered through DME, unit dose, per milligram |
0
|
12/16/2008 |
|
3 |
J7643 |
Glycopyrrolate, inhalation solution, compounded product,
administered through DME, unit dose, per mg |
0 |
12/16/2008
|
|
|
J7644 |
Ipratropium bromide, inhalation solution, FDA-aapproved final
product, non-compounded, administered through DME, unit dose form, per mg |
1
|
12/16/2008 |
|
|
J7645 |
Ipratropium bromide, inhalation solution, compounded product,
administered through DME, unit dose, per mg |
1 |
12/16/2008
|
|
|
J7668 |
Metaproterenol sulfate, inhalation solution, FDA-approved
final product, non-compounded, administesred through DME, concentrated form, per
10mg |
2
|
12/16/2008 |
|
|
J7681 |
Terbutaline sulfate, inhalant solution, compounded product,
administered through DME, unit dose form, per mg |
3 |
12/16/2008
|
|
3
|
J7685 |
Tobramycin, inhalation solution, compounded product,
administered through DME, unit dose form, per 300mg |
0 |
12/16/2008 |
|
2 |
J8501 |
Aprepitant, oral, 5 mg |
0 |
11/21/2008
|
|
2
|
J8521 |
Capecitabine, oral, 500 mg |
0 |
12/16/2008 |
|
2 |
J8530 |
Cyclophosphamide, oral, 25 mg |
0 |
12/16/2008
|
|
2
|
J8600 |
Melphalan, oral, 2mg |
0 |
12/16/2008 |
|
2 |
J8700 |
Temozolmide, oral 5 mg |
0 |
11/21/2008
|
|
2, 8
|
J8705 |
Topotecan, oral, 0.25 mg |
0 |
12/16/2008 |
|
|
J9000 |
Injection, doxorubicin hydrochoride, 10 mg |
18 |
12/16/2008
|
|
|
J9001 |
Injection, doxorubicin hydrochloride, all lipid formulations,
10 mg |
14
|
11/7/2008 |
7/1/2010 |
|
J9010 |
Injection, alemtuzumab, 10 mg |
3 |
11/7/2008
|
|
|
J9015 |
Aldesleukin, per single use vial |
6
|
12/16/2008 |
|
|
J9017 |
Injection, arsenic trioxide, 1 mg |
20 |
12/3/2008
|
1/12/2009 |
|
J9020 |
Injection, asparaginase, 10,000 units |
2 |
11/21/2008 |
|
|
J9025 |
Injection, azacitidine, 1 mg |
300 |
12/3/2008
|
|
|
J9031 |
BCG (intravesical), per instillation |
1
|
11/21/2008 |
|
8 |
J9033 |
Injection, bendamustine HCl, 1 mg |
300 |
12/16/2008
|
|
|
J9035 |
Injection, bevacizumab, 10 mg |
170
|
12/3/2008 |
Denied |
|
J9040 |
Injection, bleomycin sulfate, 15 units |
4 |
11/21/2008
|
|
|
J9041 |
Injection, bortezomib, 0.1 mg |
35
|
11/7/2008 |
|
|
J9045 |
Injection, carboplatin, 50 mg |
20 |
11/21/2008
|
Denied |
|
J9050 |
Injection, carmustine, 100 mg |
5 |
12/3/2008 |
|
|
J9055 |
Injection, cetuximab, 10 mg |
120 |
11/7/2008
|
2/27/2009 |
|
J9060 |
Cisplatin, powder or solution, per 10 mg |
24 |
12/3/2008 |
|
|
J9062 |
Cisplatin, 50 mg |
5 |
11/21/2008
|
|
|
J9065 |
Injection, cladribine, per 1 mg |
11
|
11/21/2008 |
6/1/2010 |
|
J9070 |
Cyclophosphamide, 100 mg |
55 |
12/3/2008
|
|
|
J9080 |
Cyclophosphamide, 200 mg |
19
|
12/16/2008 |
7/1/2010 |
|
J9090 |
Cyclophosphamide, 500 mg |
11 |
12/3/2008
|
|
|
J9091 |
Cyclophosphamide, 1.0 gram |
6 |
12/3/2008 |
|
|
J9092 |
Cyclophosphamide, 2.0 gram |
3 |
11/21/2008 |
|
|
J9093 |
Cyclophosphamide, lyophilized, 100 mg
|
24 |
12/3/2008 |
7/1/2010 |
|
J9094 |
Cyclophosphamide, lyophilized, 200 mg |
19
|
12/16/2008 |
7/1/2010 |
|
J9095 |
Cyclophosphamide, lyophilized, 500 mg
|
6 |
12/3/2008
|
7/1/2010 |
|
J9096 |
Cyclophosphamide, lyophilized, 1.0 gram
|
4 |
12/3/2008 |
7/1/2010
|
|
J9097
|
Cyclophosphamide, lyophilized, 2.0 gram
|
2 |
11/21/2008 |
7/1/2010 |
|
J9098 |
Injection, cytarabine liposome, 10 mg
|
5 |
11/21/2008 |
|
|
J9100
|
Injection, cytarabine, 100 mg |
3 |
11/21/2008 |
|
|
J9110 |
Injection, cytarabine, 500 mg |
10 |
11/21/2008 |
3/12/2009
|
|
J9120
|
Injection, dactinomycin, 0.5 mg |
4 |
11/21/2008 |
|
|
J9130 |
Dacarbazine, 100 mg |
10 |
12/3/2008 |
6/12/2009
|
|
J9140
|
Dacarbazine, 200 mg |
5 |
12/3/2008 |
2/27/2009 |
|
J9150 |
Injection, daunorubicin, 10 mg |
11 |
12/3/2008 |
|
| J9155 | Injection, degarelix, 1
mg | 240 | 1/1/2010 | |
|
J9160 |
Injection, denileukin diftitox, 300 micrograms |
7
|
11/21/2008 |
|
9 |
J9170 |
Injection, docetaxel, 20 mg |
12 |
11/21/2008
| |
| J9171 | Injection, docetaxel, 1
mg | 240 | 1/1/2010 | 1/8/2010 |
|
J9178 |
Injection, epirubicin HCl, 2 mg |
150
|
12/16/2008 |
|
|
J9181 |
Injection, etoposide, 10 mg |
30 |
12/3/2008
|
6/23/2009 |
|
J9182 |
Etoposide, 100 mg |
3 |
11/21/2008 |
|
|
J9185 |
Injection, fludarabine phosphate, 50 mg |
2 |
11/21/2008
|
|
|
J9190 |
Injection, fluorouracil, 500 mg |
21
|
11/21/2008 |
1/12/2009 |
|
J9200 |
Floxuridine, 500 mg |
4 |
12/16/2008
|
|
|
J9201 |
Injection, gemcitabine hydrochloride, 200 mg |
14
|
11/7/2008 |
|
|
J9202 |
Goserelin acetate implant, per 3.6 mg |
3 |
11/7/2008
|
|
|
J9206 |
Injection, irinotecan, 20 mg |
42
|
11/7/2008 |
|
8 |
J9207 |
Injection, ixabepilone, 1 mg |
105 |
12/16/2008
|
|
|
J9208 |
Injection, ifosfamide, 1 gram |
6
|
12/3/2008 |
2/27/2009 |
|
J9209 |
Injection, mesna, 200 mg |
30 |
12/3/2008
|
2/27/2009 |
|
J9211 |
Injection, idarubicin hydrochloride, 5 mg |
8 |
12/16/2008 |
|
|
J9213 |
Injection, interferon, alfa-2A, recombinant, 3 million units
|
3 |
11/21/2008
|
|
|
J9214 |
Injection, interferon, alfa-2B, recombinant, 1 million
units |
100
|
11/21/2008 |
|
3 |
J9216 |
Injection, interferon, gamma 1-B, 3 million units |
0 |
11/21/2008
|
|
|
J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
6
|
12/16/2008 |
4/24/2009 |
| J9218 |
Leuprolide acetate, per 1 mg | 1 | 7/1/2010 | |
|
J9219 |
Leuprolide acetate implant, 65 mg |
1
|
12/16/2008 |
|
|
J9225 |
Histrelin implant, 50 mg |
1 |
12/16/2008
|
|
|
J9226 |
Histrelin implant, 50 mg |
1
|
12/16/2008 |
|
|
J9230 |
Mechlorethamine HCl, (nitrogen mustard), 10 mg |
5 |
12/16/2008
|
|
|
J9245 |
Injection, melphalan HCl, 50 mg |
1
|
11/21/2008 |
|
|
J9250 |
Methotrexate sodium, 5 mg |
7200 |
12/16/2008
|
|
|
J9260 |
Methotrexate sodium, 50 mg |
720
|
12/16/2008 |
|
|
J9263 |
Injection, oxaliplatin, 0.5 mg |
624 |
12/16/2008
|
2/27/2009 |
|
J9264 |
Injection, paclitaxel protein-bound particles, 1 mg |
624 |
12/16/2008 |
|
|
J9265 |
Paclitaxel, 30 mg |
18 |
12/16/2008
|
2/27/2009 |
|
J9268 |
Injection, pentostatin, per 10 mg |
1 |
11/21/2008 |
|
|
J9280 |
Mitomycin, 5 mg |
10 |
12/16/2008
|
|
|
J9290 |
Mitomycin, 20 mg |
3
|
11/21/2008 |
|
|
J9291 |
Mitomycin, 40 mg |
2 |
11/21/2008
|
|
|
J9293 |
Injection, mitoxantrone hydrochloride, per 5 mg |
10
|
12/16/2008 |
|
|
J9300 |
Injection, gemtuzumab ozogamicin, 5 mg |
5 |
12/3/2008
|
|
|
J9303 |
Injection, panitumumab, 10 mg |
70
|
12/16/2008 |
4/20/2010 |
|
J9305 |
Injection, pemetrexed, 10 mg |
120 |
12/3/2008
|
|
|
J9310 |
Injection, rituximab, 100 mg |
11
|
11/7/2008 |
|
|
J9320 |
Injection, streptozocin, 1 gram |
4 |
12/16/2008
|
|
| J9328 | Injection, temozolomide, 1
mg | 500 | 1/1/2010 | |
8 |
J9330 |
Injection, temsirolimus, 1 mg
|
25 |
12/16/2008 |
|
|
J9340
|
Injection, thiotepa, 15 mg |
6 |
12/3/2008 |
|
|
J9350 |
Injection, topotecan, 4 mg |
10 |
12/3/2008 |
1/12/2009
|
|
J9355
|
Injection, trastuzumab, 10 mg |
88 |
11/7/2008 |
Denied |
|
J9360 |
Vinblastine sulfate, 1 mg |
45 |
12/16/2008 |
|
|
J9370
|
Vincristine sulfate, 1 mg |
4 |
12/16/2008 |
|
|
J9375 |
Vincristine sulfate, 2 mg |
2 |
12/3/2008 |
|
| J9380 | Vincristine sulfate, 5
mg | 1 | 4/1/2010 | |
|
J9390 |
Injection, vinorelbine tartrate, per 10 mg |
8
|
12/3/2008 |
|
|
J9395 |
Injection, fulvestrant, 25 mg |
20 |
11/21/2008
|
6/1/2010 |
| Q0138 | Injection ferumoxytol, for treatment
of iron deficiency anemia, 1 mg (non-ESRD use) | 510 | 1/1/2010 | |
| Q0139 | Injection ferumoxytol, for treatment
of iron deficiency anemia, 1 mg (for ESRD use) | 510 | 1/1/2010 | |
9 |
Q2024 | Injection, bevacizumab, 0.25
mg | 510 | 10/1/2009 | |
6 |
Q4083
|
Hyalgan-supartz, per dose |
2 |
11/21/2008 |
|
6 |
Q4084 |
Synvisc, per dose
|
2 |
11/21/2008 |
|
6 |
Q4085 |
Euflexxa, per dose |
2
|
11/21/2008 |
|
6 |
Q4086 |
Orthovisc, per dose |
2 |
11/21/2008
|
|